About US
Contact us
-
SFDA and the Ministry of Health jointly launch supervision and examination of vaccine supervisionIn order to enforce the quality supervision over the biological vaccines (hereinafter referred to as vaccines), improve the quality assurance in vaccine production, circulation and inoculation2010/6/18
-
Vision Inspection System Eliminated Human Limitations & Labor Costs For Polypropylene Pharmaceutical BottlesA leading maker of plastic bottles originally inspected its clarified polypropylene pharmaceutical bottles for aesthetic defects using human eyes. Adopting a machine vision inspection system eliminate2010/6/17
-
Multistage Nanovector System Provides Sustained Delivery of siRNA Cancer Therapeutic in MiceNew research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M.D. Anderson Cancer Center could make it easier for patients to u2010/6/17
-
Avista Capital Partners Commits $48.5 Million to OptiNose to Develop Nasal Delivery TechnologyAvista Capital Partners, a leading private equity firm, recently announced it has committed to invest $48.5 million in OptiNose, which has developed an innovative nasal drug delivery technolog2010/6/17
-
Multistage Nanovector System Provides Sustained Delivery of siRNA Cancer Therapeutic in MiceNew research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M.D. Anderson Cancer Center could make it easier for patients to u2010/6/13
-
BD Launches World's Smallest Pen NeedleBD (Becton, Dickinson and Company), a leading global medical technology company, recently announced the launch of BD Ultra-Fine Nano, the world's smallest pen needle. The BD Nano pen needle is2010/6/13
-
BioDelivery Sciences Announces Commercial Partnership for BEMA FentanylBioDelivery Sciences International, Inc. (BDSI) recently announced it has entered into a license and supply agreement with Kunwha Pharmaceutical Co., Ltd., for the exclusive rights to develop2010/6/13
-
Hospira & DURECT Sign Development & Commercialization AgreementHospira, Inc., a global specialty pharmaceutical and medication delivery company, and DURECT Corporation, a specialty pharmaceutical company recently announced the companies have entered into2010/6/12
-
New Mountain to Acquire Mallinckrodt BakerAn affiliate of New Mountain Capital, LLC has recently entered into a definitive agreement to acquire Mallinckrodt Baker, Inc. (MBI) from Covidien. MBI is a leading global manufacturer and sup2010/6/12
-
Bioequivalence Recommendations for Specific Products20100612(1).rar source: web of FDA2010/6/12